{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T07:12:59Z","timestamp":1719040379589},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T00:00:00Z","timestamp":1671580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T00:00:00Z","timestamp":1671580800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>We describe a patient presenting with a partial thickness subfoveal hole in the right eye after tamoxifen treatment for breast cancer.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 76-year-old Caucasian female presented with a 1-day history of acute central scotoma and blurry vision in the right eye. The patient had been receiving oral tamoxifen for 5\u00a0years as adjuvant treatment for stage I lobular breast cancer. Her past ocular history was significant for complete, uneventful, and bilateral posterior vitreous detachment. Clinical examination and optical coherence tomography revealed a new, partial thickness subfoveal hole sparing the inner retinal layers. Observation was recommended. At the last follow-up examination, 1\u00a0year after the initial presentation, the subfoveal hole remained stable and visual acuity remained stable.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Tamoxifen has been associated with a plethora of ophthalmic adverse events, including macular holes, some of which are partial thickness subfoveal holes. Holes with this almost unique morphology are uncommon, and eye care professionals should be aware of this association given the frequency of tamoxifen use, as well as the low success rate of surgical repair with pars plana vitrectomy.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13256-022-03681-4","type":"journal-article","created":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T01:43:18Z","timestamp":1671586998000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Partial thickness subfoveal hole in a patient treated with tamoxifen: a\u00a0case report and review of the literature"],"prefix":"10.1186","volume":"16","author":[{"given":"Ashley","family":"Sohn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimosthenis","family":"Mantopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,21]]},"reference":[{"issue":"10","key":"3681_CR1","doi-asserted-by":"publisher","first-page":"867","DOI":"10.3109\/02713683.2011.594202","volume":"36","author":"A Eisner","year":"2011","unstructured":"Eisner A, Luoh SW. Breast cancer medications and vision: effects of treatments for early-stage disease. Curr Eye Res. 2011;36(10):867\u201385. https:\/\/doi.org\/10.3109\/02713683.2011.594202.","journal-title":"Curr Eye Res"},{"key":"3681_CR2","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S54606","author":"T Hager","year":"2013","unstructured":"Hager T, Seitz B. Ocular side effects of biological agents in oncology: what should the clinician be aware of? OTT. 2013. https:\/\/doi.org\/10.2147\/OTT.S54606.","journal-title":"OTT"},{"issue":"3","key":"3681_CR3","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s10792-005-5424-3","volume":"26","author":"BG Cronin","year":"2006","unstructured":"Cronin BG, Lekich CK, Bourke RD. Tamoxifen therapy conveys increased risk of developing a macular hole. Int Ophthalmol. 2006;26(3):101\u20135. https:\/\/doi.org\/10.1007\/s10792-005-5424-3.","journal-title":"Int Ophthalmol"},{"issue":"4","key":"3681_CR4","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.ajo.2005.04.042","volume":"140","author":"V Gualino","year":"2005","unstructured":"Gualino V, Cohen SY, Delyfer MN, Sahel JA, Gaudric A. Optical coherence tomography findings in tamoxifen retinopathy. Am J Ophthalmol. 2005;140(4):757\u20138. https:\/\/doi.org\/10.1016\/j.ajo.2005.04.042.","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"3681_CR5","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s10549-006-9187-y","volume":"99","author":"MF Martine","year":"2006","unstructured":"Martine MF, Jo\u00ebl G, Maddalena QEM. Optical coherence tomography in tamoxifen retinopathy. Breast Cancer Res Treat. 2006;99(1):117\u20138. https:\/\/doi.org\/10.1007\/s10549-006-9187-y.","journal-title":"Breast Cancer Res Treat"},{"key":"3681_CR6","doi-asserted-by":"publisher","DOI":"10.3205\/OC000007","author":"A Caramoy","year":"2011","unstructured":"Caramoy A, Scholz P, Fauser S, Kirchhof B. Imaging tamoxifen retinopathy using spectral-domain optical coherence tomography. GMS Ophthalmol Cases. 2011. https:\/\/doi.org\/10.3205\/OC000007.","journal-title":"GMS Ophthalmol Cases"},{"issue":"7","key":"3681_CR7","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1097\/IAE.0b013e31813c69f7","volume":"27","author":"PS Bernstein","year":"2007","unstructured":"Bernstein PS, DellaCroce JT. Diagnostic & therapeutic challenges. Tamoxifen toxicity. Retina. 2007;27(7):982\u20138. https:\/\/doi.org\/10.1097\/IAE.0b013e31813c69f7.","journal-title":"Retina"},{"issue":"3","key":"3681_CR8","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1159\/000508327","volume":"11","author":"N Torrell-Belzach","year":"2020","unstructured":"Torrell-Belzach N, Vela Segarra JI, Cresp\u00ed Vilimelis J, Alhayek M. Bilateral macular hole related to tamoxifen low-dose toxicity. Case Rep Ophthalmol. 2020;11(3):528\u201333. https:\/\/doi.org\/10.1159\/000508327.","journal-title":"Case Rep Ophthalmol"},{"issue":"5","key":"3681_CR9","doi-asserted-by":"publisher","first-page":"306","DOI":"10.3341\/kjo.2010.24.5.306","volume":"24","author":"SE Chung","year":"2010","unstructured":"Chung SE, Kim SW, Chung HW, Kang SW. Estrogen antagonist and development of macular hole. KJO. 2010;24(5):306\u20139. https:\/\/doi.org\/10.3341\/kjo.2010.24.5.306.","journal-title":"KJO"},{"key":"3681_CR10","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S38951","author":"I Georgalas","year":"2013","unstructured":"Georgalas I, Paraskevopoulos, Papaconstantinou D, Ladas I, Brouzas D, Chryssanthi K. Large bilateral foveal cysts in the inner retina of a patient treated with tamoxifen, diagnosed with Fourier-domain optical coherence tomography. OPTH. 2013. https:\/\/doi.org\/10.2147\/OPTH.S38951.","journal-title":"OPTH"},{"issue":"6","key":"3681_CR11","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/j.ajo.2014.02.046","volume":"157","author":"RR Doshi","year":"2014","unstructured":"Doshi RR, Fortun JA, Kim BT, Dubovy SR, Rosenfeld PJ. Pseudocystic foveal cavitation in tamoxifen retinopathy. Am J Ophthalmol. 2014;157(6):1291-1298.e3. https:\/\/doi.org\/10.1016\/j.ajo.2014.02.046.","journal-title":"Am J Ophthalmol"},{"key":"3681_CR12","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.pdpdt.2016.10.004","volume":"17","author":"Y Hu","year":"2017","unstructured":"Hu Y, Liu N, Chen Y. The optical imaging and clinical features of tamoxifen associated macular hole: a case report and review of the literatures. Photodiagn Photodyn Ther. 2017;17:35\u20138. https:\/\/doi.org\/10.1016\/j.pdpdt.2016.10.004.","journal-title":"Photodiagn Photodyn Ther"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-022-03681-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-022-03681-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-022-03681-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T01:43:23Z","timestamp":1671587003000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-022-03681-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,21]]},"references-count":12,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["3681"],"URL":"https:\/\/doi.org\/10.1186\/s13256-022-03681-4","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,21]]},"assertion":[{"value":"8 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study adhered to the tenets of the Declaration of Helsinki and adhered with HIPAA. Retrospective review of patient data for this case report did not require IRB approval according to local guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"DM reports consulting fees from Alimera Sciences. AS and GS declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"471"}}